T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Acadia Realty Trust
AKR
$2.86B
| $175M | 0.04% |
6,228,503
+990,364
| +19% | +$27.1M |
|
477
Western Alliance Bancorporation
WAL
$8.92B
| $175M | 0.04% |
7,341,547
-91,130
| -1% | -$2.14M |
|
|
WRI
478
DELISTED
Weingarten Realty Investors
WRI
| $175M | 0.04% |
5,317,093
-416,783
| -7% | -$13.1M |
|
|
SC
479
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $174M | 0.04% |
8,972,520
-2,284,629
| -20% | -$48.8M |
|
|
PDCE
480
DELISTED
PDC Energy, Inc.
PDCE
| $174M | 0.04% |
2,757,794
-356,329
| -11% | -$22.4M |
|
481
Capitol Federal Financial
CFFN
$1.09B
| $173M | 0.04% |
14,225,611
-190,570
| -1% | -$2.32M |
|
482
Colgate-Palmolive
CL
$74.1B
| $173M | 0.04% |
2,533,811
-2,564
| -0.1% | -$172K |
|
|
SEM
483
DELISTED
Select Medical
SEM
| $171M | 0.04% |
20,333,746
-920,101
| -4% | -$7.13M |
|
484
Edgewell Personal Care
EPC
$1.31B
| $170M | 0.04% |
1,880,749
-98,935
| -5% | -$8.14M |
|
|
XOOM
485
DELISTED
XOOM CORP COM
XOOM
| $169M | 0.04% |
6,427,310
-73,270
| -1% | -$1.63M |
|
|
ZU
486
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $169M | 0.04% |
4,115,244
+171,953
| +4% | +$6.92M |
|
|
487
eBay
EBAY
$46.5B
| $167M | 0.04% |
7,924,941
-35,028,335
| -82% | -$763M |
|
|
DTV
488
DELISTED
DIRECTV COM STK (DE)
DTV
| $166M | 0.04% |
1,950,859
+1,174,704
| +151% | +$95.7M |
|
489
Host Hotels & Resorts
HST
$15.6B
| $165M | 0.04% |
7,484,508
+80,726
| +1% | +$1.74M |
|
|
BECN
490
DELISTED
Beacon Roofing Supply, Inc.
BECN
| $165M | 0.04% |
4,968,730
+2,012,700
| +68% | +$70.7M |
|
491
Camden Property Trust
CPT
$11.1B
| $164M | 0.04% |
2,304,821
+58,081
| +3% | +$4.04M |
|
492
Terex
TEX
$7.56B
| $164M | 0.04% |
3,984,469
+2,176,984
| +120% | +$88.5M |
|
493
RPM International
RPM
$14.5B
| $162M | 0.04% |
3,510,269
+767,149
| +28% | +$33.2M |
|
494
Southwest Gas
SWX
$6.68B
| $161M | 0.03% |
3,052,720
+11,510
| +0.4% | +$610K |
|
495
MakeMyTrip
MMYT
$5.71B
| $161M | 0.03% |
4,579,805
-463,523
| -9% | -$11.8M |
|
496
Goldman Sachs
GS
$303B
| $161M | 0.03% |
960,194
-133,162
| -12% | -$21.5M |
|
|
KKD
497
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $161M | 0.03% |
10,046,124
-81,130
| -0.8% | -$1.41M |
|
|
GMCR
498
DELISTED
KEURIG GREEN MTN INC
GMCR
| $160M | 0.03% |
1,285,214
+120,706
| +10% | +$13.2M |
|
|
CBST
499
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $160M | 0.03% |
2,291,443
-41,985
| -2% | -$2.86M |
|
500
DexCom
DXCM
$34.5B
| $159M | 0.03% |
15,993,200
+4,740,400
| +42% | +$42M |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.